THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction

被引:0
作者
J M Jansma
H H van Hell
L J M J Vanderschuren
M G Bossong
G Jager
R S Kahn
N F Ramsey
机构
[1] Rudolf Magnus Institute of Neuroscience,Department of Neurology and Neurosurgery
[2] University Medical Center Utrecht,Department of Neuroscience and Pharmacology
[3] Rudolf Magnus Institute of Neuroscience,Department of Animals in Science and Society, Division of Behavioural Neuroscience
[4] University Medical Center Utrecht,Department of Psychosis Studies
[5] Faculty of Veterinary Medicine,Division of Human Nutrition
[6] Utrecht University,Department of Psychiatry
[7] King’s College,undefined
[8] Institute of Psychiatry,undefined
[9] Wageningen University,undefined
[10] Rudolf Magnus Institute of Neuroscience,undefined
[11] University Medical Center Utrecht,undefined
来源
Translational Psychiatry | 2013年 / 3卷
关键词
endocannabinoid system; functional MRI; nicotine addiction; nucleus accumbens; reward; THC;
D O I
暂无
中图分类号
学科分类号
摘要
Recent evidence has implicated the endocannabinoid (eCB) system in nicotine addiction. The eCB system also has an important role in reward mechanisms, and nicotine addiction has been associated with aberrant reward processing. Motivated by this evidence, we tested the hypothesis that eCB modulation of reward processing is altered in subjects with a nicotine addiction (NAD). For this purpose, we compared reward-related activity in NAD with healthy controls (HC) in a pharmacological magnetic resonance imaging (MRI) study using Δ9-tetrahydrocannabinol (THC) administration to challenge the eCB system. Eleven HC and 10 NAD participated in a 3-T functional MRI (fMRI) study with a double-blind, cross-over, placebo-controlled design, using a Monetary Incentive Delay (MID) paradigm with three reward levels. Reward activity in the nucleus accumbens (NAcc) and caudate putamen during anticipation and feedback of reward was compared after THC and placebo. fMRI results indicated a significant reduction of reward anticipation activity in the NAcc in NAD after THC administration, which was not present in HC. This is indicated by a significant group by drug by reward interaction. Our data show that THC significantly reduces the NAcc response to monetary reward anticipation in NAD. These results suggest that nicotine addiction is associated with altered eCB modulation of reward processing in the NAcc. This study adds important human data to existing evidence implicating the eCB system in nicotine addiction.
引用
收藏
页码:e234 / e234
相关论文
共 248 条
  • [1] Maldonado R(2006)Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 225-232
  • [2] Valverde O(2005)The role of the cannabinoid system in nicotine addiction Pharmacol Biochem Behav 81 381-386
  • [3] Berrendero F(2008)Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies Addict Biol 13 239-252
  • [4] Castañé A(2002)Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine Br J Pharmacol 135 564-578
  • [5] Berrendero F(2008)The endocannabinoid system: a new molecular target for the treatment of tobacco addiction CNS Neurol Disord Drug Targets 7 468-481
  • [6] Maldonado R(2012)The genetic basis of the endocannabinoid system and drug addiction in humans J Psychopharmacol 26 133-143
  • [7] Le Foll B(2002)SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats Behav Pharmacol 13 451-463
  • [8] Forget B(2005)Cannabinoid CB1 receptors control conditioned drug seeking Trends Pharmacol Sci 26 420-426
  • [9] Aubin HJ(2011)Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition PloS ONE 6 e28142-150
  • [10] Goldberg SR(2007)Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation Cochrane Database Syst Rev 17 CD005353-383